| Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1 TH Lee, S Seng, M Sekine, C Hinton, Y Fu, HK Avraham, S Avraham PLoS medicine 4 (6), e186, 2007 | 345 | 2007 |
| Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain CV Hinton, S Avraham, HK Avraham Clinical & experimental metastasis 27, 97-105, 2010 | 154 | 2010 |
| PTEN regulation of ERK1/2 signaling in cancer MA Chetram, CV Hinton Journal of Receptors and Signal Transduction 32 (4), 190-195, 2012 | 124 | 2012 |
| Simultaneous activation of induced heterodimerization between CXCR4 chemokine receptor and cannabinoid receptor 2 (CB2) reveals a mechanism for regulation of tumor progression CJ Coke, KA Scarlett, MA Chetram, KJ Jones, BJ Sandifer, AS Davis, ... Journal of Biological Chemistry 291 (19), 9991-10005, 2016 | 93 | 2016 |
| ROS enhances CXCR4-mediated functions through inactivation of PTEN in prostate cancer cells MA Chetram, AS Don-Salu-Hewage, CV Hinton Biochemical and biophysical research communications 410 (2), 195-200, 2011 | 83 | 2011 |
| Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells MA Chetram, V Odero-Marah, CV Hinton Molecular cancer research 9 (1), 90-102, 2011 | 72 | 2011 |
| ROS-mediated activation of AKT induces apoptosis via pVHL in prostate cancer cells MA Chetram, DA Bethea, VA Odero-Marah, AS Don-Salu-Hewage, ... Molecular and cellular biochemistry 376, 63-71, 2013 | 71 | 2013 |
| Cysteine (C)-xC receptor 4 undergoes transportin 1-dependent nuclear localization and remains functional at the nucleus of metastatic prostate cancer cells AS Don-Salu-Hewage, SY Chan, KM McAndrews, MA Chetram, ... PloS one 8 (2), e57194, 2013 | 69 | 2013 |
| Agonist-induced CXCR4 and CB2 heterodimerization inhibits Gα13/RhoA-mediated migration KA Scarlett, ESZ White, CJ Coke, JR Carter, LK Bryant, CV Hinton Molecular Cancer Research 16 (4), 728-739, 2018 | 50 | 2018 |
| Serum deprivation initiates adaptation and survival to oxidative stress in prostate cancer cells ESZ White, NM Pennant, JR Carter, O Hawsawi, V Odero-Marah, ... Scientific reports 10 (1), 12505, 2020 | 48 | 2020 |
| Proteomics-metabolomics combined approach identifies peroxidasin as a protector against metabolic and oxidative stress in prostate cancer J Dougan, O Hawsawi, LJ Burton, G Edwards, K Jones, J Zou, ... International Journal of Molecular Sciences 20 (12), 3046, 2019 | 39 | 2019 |
| ROS-mediated regulation of CXCR4 in cancer MA Chetram, CV Hinton Frontiers in biology 8, 273-278, 2013 | 37 | 2013 |
| p62/SQSTM1 is required for cell survival of apoptosis‐resistant bone metastatic prostate cancer cell lines MA Chang, M Morgado, CR Warren, CV Hinton, MC Farach‐Carson, ... The Prostate 74 (2), 149-163, 2014 | 32 | 2014 |
| Phosphatidylinositol 3-kinase/Akt signaling enhances nuclear localization and transcriptional activity of BRCA1 CV Hinton, LD Fitzgerald, ME Thompson Experimental cell research 313 (9), 1735-1744, 2007 | 31 | 2007 |
| Camalexin-induced apoptosis in prostate cancer cells involves alterations of expression and activity of lysosomal protease cathepsin D B Smith, D Randle, R Mezencev, LS Thomas, C Hinton, V Marah Molecules 19 (4), 3988-4005, 2014 | 27 | 2014 |
| Contributions of integrin‐linked kinase to breast cancer metastasis and tumourigenesis CV Hinton, S Avraham, HK Avraham Journal of cellular and molecular medicine 12 (5a), 1517-1526, 2008 | 27 | 2008 |
| The phytoalexin camalexin mediates cytotoxicity towards aggressive prostate cancer cells via reactive oxygen species BA Smith, CL Neal, M Chetram, BH Vo, R Mezencev, C Hinton, ... Journal of natural medicines 67, 607-618, 2013 | 25 | 2013 |
| Cysteine (C)-XC receptor 4 regulates NADPH oxidase-2 during oxidative stress in prostate cancer cells KJ Jones, MA Chetram, DA Bethea, LK Bryant, V Odero-Marah, CV Hinton Cancer Microenvironment 6, 277-288, 2013 | 23 | 2013 |
| Community engagement practices at research centers in US minority institutions: priority populations and innovative approaches to advancing health disparities research T Henry Akintobi, P Sheikhattari, E Shaffer, CL Evans, KL Braun, AU Sy, ... International journal of environmental research and public health 18 (12), 6675, 2021 | 10 | 2021 |
| Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models L Bai, X Li, Y Yang, R Zhao, EZ White, A Danaher, NJ Bowen, CV Hinton, ... Translational Oncology 34, 101707, 2023 | 4 | 2023 |
